Qiagen (NYSE: QGEN) reported Q2 EPS of $0.46, $0.02 better than the analyst estimate of $0.44. Revenue for the quarter came in at $459 million versus the consensus estimate of $453.91 million.

GUIDANCE:

Qiagen sees FY2024 EPS of $2.10, versus the consensus of $2.11. Qiagen sees FY2024 revenue of $2 billion, versus the consensus of $2.01 billion.
For Q2 2024, net sales are expected to be at least $495 million CER, versus the consensus of $501.1 million CER while adjusted diluted EPS are expected to be at least $0.52 CER per share, in -line with the consensus.

For earnings history and earnings-related data on Qiagen (QGEN) click here.